1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

$1.5 Million Award in Autistic Child Tardive Dyskinesia Malpractice

Antipsychotic Drugs Prescribed by Psychiatrist Caused Permanent Disabling Adverse Effect

 
PRLog - Feb. 17, 2014 - A Chicago jury has awarded $1.5 million dollars to an autistic child who developed a severe case of tardive dyskinesia and tardive akathisia while being treated by psychiatrists with Risperdal and then Zyprexa between 2002 and 2007. The jury decision was handed down on February 11, 2014.  The drug-induced disorder was diagnosed when he was fifteen years old and by then had become disabling and irreversible.
   Tardive dyskinesia describes a group of persistent or permanent movement disorders caused by antipsychotic (neuroleptic) drugs including Risperdal, Zyprexa, Invega, Abilify, Geodon, Seroquel, Latuda, Fanapt and Saphris.  In addition to typical tardive dyskinesia spasms and twitches of his face, eyelids, and tongue, the youngster developed a severe case of tardive akathisia involving torturous internal agitation that drove him into constant, unrelenting motion.
   According to Ithaca, New York psychiatrist Peter R. Breggin, MD, a medical expert in the case, the boy was diagnosed with autism as a child and then started on SSRI antidepressants before the age of seven.   He continued to be treated with the antidepressants Zoloft and then Paxil which caused his mental condition and behavior to deteriorate.  Dr. Breggin testified in court that these drugs very frequently cause anxiety, depression, aggression, mania and out-of-control behavior in children.
   Instead of removing the child from the offending antidepressants, his first psychiatrist started him on Risperdal (risperidone).  His second psychiatrist, Howard Segal, MD, who was the defendant in the case, continued him on Risperdal and then Zyprexa for two and one half years, despite the appearance of tardive dyskinesia symptoms.  Dr.  Breggin explained to the jury how antipsychotic drugs cause tardive dyskinesia at a high rate in children and adults, and how the doctor’s negligent actions caused the boy to develop severe tardive dyskinesia and tardive akathisia.
   In response to the jury verdict, Dr. Breggin stated that psychiatric drugs do much more harm than good in treating autistic children and that he hoped the case would serve as a reminder and an alert that autistic children (like all distressed children) need caring psychological, social and educational interventions, and not psychiatric drugs.
   Dr. Breggin is the author of many scientific articles and books.  His most recent book is Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families.  His website is www.breggin.com.
   The Chicago attorney in the case was Francis P. Morrissey.  The malpractice case was Angel v. Segal, State of Illinois, In the Circuit Court of Cook Count, Illinois, County Department, Law Division, No. 09 L 3496.

Contact
Peter R. Breggin M.D.
607-272-5328
***@hotmail.com

--- End ---

Click to Share

Contact Email:
***@hotmail.com Email Verified
Source:Peter R. Breggin M.D.
Location:United States
Industry:Legal
Tags:peter breggin md, tardive dyskinesia, antipsychotics, autism, risperdal
Shortcut:prlog.org/12283947
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share